The Patent Finder

Immunovaccine Technologies Inc.

Also on record
Records under this name other than patents Immunovaccine Technologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Immunovaccine Technologies Inc.

PatentTitleStatus Expires Confidence
US 10,232,052Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase for Delivery of Polynucleotides in Vivo
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,717,563Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,729,766Method for Improving the Efficacy of a Survivin Vaccine in the Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,533,033Lipid a Mimics, Methods of Preparation, and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,042,537Methods of Using Low Dose Volume B-Cell Epitope Compositions for Inducing an Antibody Immune Response in Human Subjects
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,105,435Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
Formerly held
Lapsed on the fee record
Ended Oct 23, 2026 · Low confidence
Lapsed on the fee recordEnded Oct 23, 2026Low confidence
US 10,272,042Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
Formerly held
Term ended
Term ended Oct 5, 2026 · Medium confidence
Term endedTerm ended Oct 5, 2026Medium confidence
US 11,406,705Methods of Using Low Dose Volume B-cell Epitope Compositions for Inducing an Antibody Immune Response in Human Subjects
Formerly held
Lapsed on the fee record
Ended Aug 9, 2026 · High confidence
Lapsed on the fee recordEnded Aug 9, 2026High confidence
US 10,022,441Method for Improving the Efficacy of a Survivin Vaccine in the Treatment of Cancer
Formerly held
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 9,925,142Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
Formerly held
Lapsed on the fee record
Ended Mar 27, 2026 · Low confidence
Lapsed on the fee recordEnded Mar 27, 2026Low confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited